These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38197965)

  • 1. Altered expression of Sialyl Lewis X in experimental models of Parkinson's disease.
    Nunes MJ; Carvalho AN; Rosa AI; Videira PA; Gama MJ; Rodrigues E; Castro-Caldas M
    J Mol Med (Berl); 2024 Mar; 102(3):365-377. PubMed ID: 38197965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
    Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
    J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease.
    González H; Contreras F; Prado C; Elgueta D; Franz D; Bernales S; Pacheco R
    J Immunol; 2013 May; 190(10):5048-56. PubMed ID: 23589621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N; Beiping H; Dheen ST; Tay SS
    Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
    Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
    Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain Selective Estrogen Treatment Protects Dopaminergic Neurons and Preserves Behavioral Function in MPTP-induced Mouse Model of Parkinson's Disease.
    Thadathil N; Xiao J; Hori R; Alway SE; Khan MM
    J Neuroimmune Pharmacol; 2021 Sep; 16(3):667-678. PubMed ID: 33221984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease.
    Pattarini R; Smeyne RJ; Morgan JI
    Neuroscience; 2007 Mar; 145(2):654-68. PubMed ID: 17258864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Amniotic Epithelial Cells Alleviate a Mouse Model of Parkinson's Disease Mainly by Neuroprotective, Anti-Oxidative and Anti-Inflammatory Factors.
    Zhang J; Li H; Yang H; Lin J; Wang Y; Zhang Q; Gao WQ; Xu H
    J Neuroimmune Pharmacol; 2021 Sep; 16(3):620-633. PubMed ID: 33164162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DAP12 and CD11b contribute to the microglial-induced death of dopaminergic neurons in vitro but not in vivo in the MPTP mouse model of Parkinson's disease.
    Kinugawa K; Monnet Y; Béchade C; Alvarez-Fischer D; Hirsch EC; Bessis A; Hunot S
    J Neuroinflammation; 2013 Jul; 10():82. PubMed ID: 23844828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired CBS-H
    Yuan YQ; Wang YL; Yuan BS; Yuan X; Hou XO; Bian JS; Liu CF; Hu LF
    Brain Behav Immun; 2018 Jan; 67():77-90. PubMed ID: 28774789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal SH2B1 attenuates apoptosis in an MPTP mouse model of Parkinson's disease via promoting PLIN4 degradation.
    Han X; Liu Y; Dai Y; Xu T; Hu Q; Yi X; Rui L; Hu G; Hu J
    Redox Biol; 2022 Jun; 52():102308. PubMed ID: 35390677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoembryonic antigen is a sialyl Lewis x/a carrier and an E‑selectin ligand in non‑small cell lung cancer.
    Ferreira IG; Carrascal M; Mineiro AG; Bugalho A; Borralho P; Silva Z; Dall'olio F; Videira PA
    Int J Oncol; 2019 Nov; 55(5):1033-1048. PubMed ID: 31793656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
    Pariyar R; Bastola T; Lee DH; Seo J
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D Treatment Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in an Animal Model of Parkinson's Disease, Shifting M1 to M2 Microglia Responses.
    Calvello R; Cianciulli A; Nicolardi G; De Nuccio F; Giannotti L; Salvatore R; Porro C; Trotta T; Panaro MA; Lofrumento DD
    J Neuroimmune Pharmacol; 2017 Jun; 12(2):327-339. PubMed ID: 27987058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson's disease mouse model.
    Sun Q; Wang S; Chen J; Cai H; Huang W; Zhang Y; Wang L; Xing Y
    J Cell Physiol; 2019 Dec; 234(12):23379-23387. PubMed ID: 31232472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced dopaminergic neuron degeneration and global transcriptional changes in Parkinson's disease mouse brains engrafted with human neural stems during the early disease stage.
    Pereira MCL; Boese AC; Murad R; Yin J; Hamblin MH; Lee JP
    Exp Neurol; 2022 Jun; 352():114042. PubMed ID: 35271839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin.
    Santoro M; Maetzler W; Stathakos P; Martin HL; Hobert MA; Rattay TW; Gasser T; Forrester JV; Berg D; Tracey KJ; Riedel G; Teismann P
    Neurobiol Dis; 2016 Jul; 91():59-68. PubMed ID: 26921471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Regulatory Mechanism and Toxicology of Neurodegenerative Processes in MPTP/Probenecid-Induced Progressive Parkinson's Disease Mice Model Revealed by Transcriptome.
    Yang W; Hao W; Meng Z; Ding S; Li X; Zhang T; Huang W; Xu L; Zhang Y; Yang J; Gu X
    Mol Neurobiol; 2021 Feb; 58(2):603-616. PubMed ID: 32997292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease model.
    Qi X; Davis B; Chiang YH; Filichia E; Barnett A; Greig NH; Hoffer B; Luo Y
    J Neurochem; 2016 Sep; 138(5):746-57. PubMed ID: 27317935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.